Neil F. McFarlane

Mr. McFarlane has served as our President, Chief Executive Officer and member of the board of directors since October 2023. He previously served as the Chief Executive Officer and a member of the Board of Directors for Adamas Pharmaceuticals, Inc. until November 2021, when Adamas was acquired by Supernus Pharmaceuticals, Inc. Prior to Adamas, Mr. McFarlane served as the Chief Operating Officer of Retrophin, Inc. (now Travere Therapeutics, Inc.). Prior to his position at Retrophin, Mr. McFarlane held positions of increasing responsibility with UCB, Inc., Genzyme Corporation (now Sanofi) and Sangstat Medical Corporation (acquired by Genzyme). Mr. McFarlane currently serves on the Board of Directors for Collegium Pharmaceuticals, Inc. He proudly served as an officer and enlisted soldier in the United States Army Reserves, and earned his B.S. and M.S. in Nursing from the University of Florida.